EMBI Insider Trading Activity and SEC Form 4 Filings
EMBI insider trading summary
No open-market insider purchases or sales of Emerald Bioscience, Inc. (EMBI) have been reported on SEC Form 4 in the past 12 months.
Latest EMBI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 7, 2020 | James L Heppell | Insider | Buy | $25.00B (500,000 @ $50000.00) |
| Aug 7, 2020 | Punit Dhillon | CEO | Buy | $100.00B (1,000,000 @ $100000.00) |
| Aug 7, 2020 | Emerald Health Sciences Inc. | Insider | Sell | $300K (3,000,000 @ $0.10) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.